WCLC 2025 - Posters & ePosters-P1.11.46 RATIONALE-303: Post-Hoc Analysis of Tislelizumab Monotherapy in Previously Treated Non-Small Cell Lung Cancer With Metastases

P1.11.46 RATIONALE-303: Post-Hoc Analysis of Tislelizumab Monotherapy in Previously Treated Non-Small Cell Lung Cancer With Metastases

Asset Subtitle

Kirsha Naicker

Meta Tag

Speaker Kirsha Naicker

Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy